Focus on Managed Care Pharmacy

(M5) Views on Value-Based Contracts: Aligning Payers and Manufacturers for Success

Thursday, March 23, 2023

2:45 PM – 4:00 PM

Location: B1

ACPE UAN:0233-0000-23-010-L99-P | Contact Hours: 1.25 | Activity Type: Knowledge-based

Faculty(s)

Jane F. Barlow, MD, MPH, MBA

Chief Clinical Officer
Real Endpoints
Scottsdale, AZ
Michael A. Ford, RPh (he/him/his)

Executive Director, Value Based Care Council
National Association of Managed Care Physicians
Richmond, VA

Moderator(s)

Dean Hakanson, MD

Chief Medical Officer
Coeus Consulting Group
San Mateo, California

Value-based contracting between payers and pharmaceutical manufacturers is gaining attention, especially for the reimbursement of orphan disease drugs, which typically come with high costs and potential clinical uncertainty.

Understanding the goals and barriers for each stakeholder can pave the way to best utilize value-based contracts and ensure these agreements are mutually beneficial. This interactive session will leverage recent survey data from payers and manufacturers to better align both parties and catalyze the next generation of agreements for sustained patient access to transformative therapies.

Learning Objectives::

At the completion of this activity, participants should be able to:

Summarize the role of value-based contracts and the current utilization of these types of contracts.
Identify opportunities to align across stakeholders to facilitate patient access to innovative therapies.
Based on current surveys of the views of payers and pharmaceutical manufacturers, recognize two scenarios for the use of value-based contracts.
List two recommendations on how to catalyze the successful adoption of innovative contracting.